Inhibitory effect of luteinising hormone-releasing hormone analogues on human endometrial cancer in vitro (original) (raw)
Differential Inhibitory Effects on Human Endometrial Carcinoma Cell Growth of Luteinizing Hormone-Releasing Hormone Analogues
Francesca Torricelli
Gynecologic Oncology, 1998
View PDFchevron_right
Effective treatment of experimental human endometrial cancers with targeted cytotoxic luteinizing hormone–releasing hormone analogues AN-152 and AN-207
Attila Nagy
Fertility and Sterility, 2005
View PDFchevron_right
Regulation of endometrial cancer cell growth by luteinizing hormone (LH) and follicle stimulating hormone (FSH)
Ray Iles
British journal of …, 2000
View PDFchevron_right
Inhibitory activity of luteinizing hormone-releasing hormone on tumor growth and progression
Patrizia Limonta
Endocrine-related Cancer, 2003
View PDFchevron_right
Antiproliferative effects of luteinizing hormone-releasing hormone agonists on the human prostatic cancer cell line LNCaP
Patrizia Limonta
The Journal of Clinical Endocrinology & Metabolism, 1992
View PDFchevron_right
Antiproliferative Effects of Luteinizing Hormone-releasing Hormone (LHRH) Agonists on Human Androgen-independent Prostate Cancer Cell Line DU 145: Evidence for an Autocrine-inhibitory LHRH Loop
Marina Marelli
Cancer Research
View PDFchevron_right
Expression of receptors for luteinizing hormone-releasing hormone in human ovarian and endometrial cancers: Frequency, autoregulation, and correlation with direct antiproliferative activity of luteinizing hormone-releasing hormone analogues
Csongor Kiss
American Journal of Obstetrics and Gynecology, 2002
View PDFchevron_right
Direct effects of GnRH agonists in human hormone-sensitive endometrial cells
Fortunata Iacopino, Cristiana Angelucci
Molecular and cellular endocrinology, 2001
View PDFchevron_right
Longstanding survival without cancer progression in a patient affected by endometrial carcinoma treated primarily with leuprolide
A. Arcangeli
British Journal of Cancer, 2001
View PDFchevron_right
Effect of GnRH analogues and octreotide treatment on apoptosis and the cell proliferation of endometrium adenocarcinoma cell lines
Birol Vural
View PDFchevron_right
Inhibition of growth of OV-1063 human epithelial ovarian cancer xenografts in nude mice by treatment with luteinizing hormone-releasing hormone antagonist SB-75
G. Halmos
Proceedings of the National Academy of Sciences, 1994
View PDFchevron_right
Targeting of Cytotoxic Luteinizing Hormone-Releasing Hormone Analogs to Breast, Ovarian, Endometrial, and Prostate Cancers1
Attila Nagy
Biology of Reproduction, 2005
View PDFchevron_right
Luteinizing hormone increases human endometrial cancer cells invasiveness through activation of protein kinase A
Manuela Balzi
Cancer research, 2003
View PDFchevron_right
Cytotoxic analogs of luteinizing hormone-releasing hormone bind with high affinity to human breast cancers
Andrew Schally
Cancer Letters, 1999
View PDFchevron_right
hLH/hCG-receptor expression correlates with in vitro invasiveness in human primary endometrial cancer
Gianfranco Scarselli
Gynecologic Oncology, 2008
View PDFchevron_right
Over-Expression of the LH Receptor Increases Distant Metastases in an Endometrial Cancer Mouse Model
Ivo Noci
Frontiers in Oncology, 2013
View PDFchevron_right
Cellular Mechanisms of Growth Inhibition of Human Epithelial Ovarian Cancer Cell Line by LH-Releasing Hormone Antagonist Cetrorelix
Koji Kugu
The Journal of Clinical Endocrinology & Metabolism, 2002
View PDFchevron_right
Transgenic mice overexpressing the LH receptor in the female reproductive system spontaneously develop endometrial tumour masses
Ivo Noci
Scientific Reports, 2021
View PDFchevron_right
Targeted cytotoxic analog of luteinizing hormone–releasing hormone AN-207 inhibits growth of OV-1063 human epithelial ovarian cancers in nude mice☆☆☆★
Andrew Schally, N. Block
American Journal of Obstetrics and Gynecology, 1999
View PDFchevron_right
Triple-negative breast cancers express receptors for luteinizing hormone-releasing hormone (LHRH) and respond to LHRH antagonist Cetrorelix with growth …
Ferenc Rick
Int J Oncol, 2009
View PDFchevron_right
Receptors for Luteinizing Hormone Releasing Hormone Expressed on Human Renal Cell Carcinomas Can Be Used for Targeted Chemotherapy with Cytotoxic Luteinizing Hormone Releasing Hormone Analogues
Matyas Fekete
View PDFchevron_right
Regulation of gene expression in ovarian cancer cells by luteinizing hormone receptor expression and activation
Susanne Warrenfeltz, David Puett
BMC Cancer, 2011
View PDFchevron_right
Gonadotropin-releasing hormone agonist induces apoptosis and reduces cell proliferation in eutopic endometrial cultures from women with endometriosis* 1
Marta Tesone
Fertility and sterility, 2003
View PDFchevron_right
LH-RH and Its Antagonist Cetrorelix Inhibit Growth of Jar Human Choriocarcinoma Cells In-Vitro
Tibor Ertl
International Journal of Oncology, 1995
View PDFchevron_right
Triple-negative breast cancers express receptors for luteinizing hormone-releasing hormone (LHRH) and respond to LHRH antagonist cetrorelix with growth inhibition
Frank Köster
2009
View PDFchevron_right
Gonadotropin-releasing hormone agonist induces apoptosis and reduces cell proliferation in eutopic endometrial cultures from women with endometriosis
Massimiliano Farina
Fertility and Sterility, 2003
View PDFchevron_right
Pharmacological studies with cetrorelix (SB-75), a potent antagonist of luteinising hormone-releasing hormone
Peter Hilgard
European Journal of Cancer, 1996
View PDFchevron_right
Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists
George Tolis
Proceedings of the National Academy of Sciences, 1982
View PDFchevron_right
Luteinizing hormone-releasing hormone antagonists
Gábor Mezo
Expert Opinion on Therapeutic Patents, 2009
View PDFchevron_right
Regulatory Actions of LH and Follicle-Stimulating Hormone on Breast Cancer Cells and Mammary Tumors in Rats
eleonora russo
Frontiers in endocrinology, 2018
View PDFchevron_right
Regulation of endometrial cancer cell growth by insulin-like growth factors and the luteinizing hormone-releasing hormone antagonist SB-75
Ray Iles
Regulatory Peptides, 1993
View PDFchevron_right